Biography
Dr. Chryssostomos Chatgilialoglu was appointed Director of the Institute of Nanoscience and Nanotechnology (INN) in the NCSR “Demokritosâ€, Athens, in March 2014. He is also the Honorary President and Co-founder of spin-off companies Lipinutragen (Italy) and Lipinutramed (Greece). He chaired the COST Action CM0603 on Free Radicals in Chemical Biology, from 2007 to 2011, and is now the Chairman of the COST Action CM1201 on Biomimetic Radical Chemistry, running from 2012 to 2016. In 1976, he received his doctorate degree in Industrial Chemistry from the University of Bologna and completed his postdoctoral studies at York University (UK) and National Research Council of Canada, Ottawa. From 1983, he worked for the Consiglio Nazionale delle Ricerche (Bologna), and was Research Director from 1991 to 2014. He has received many honors and awards including the Fluka Prize “Reagent of the Year 1990â€, and is a world-expert in free radicals. He has published over 240 papers in peer-reviewed international journals (>7,500 citations, h-index 43), 33 book chapters, 6 patents, and 7 books (3 as author and 4 edited); Co-Editor of the Encyclopedia of Radical in Chemistry, Biology and Materials (4 volumes), 2012 John Wiley & Sons, Ltd. Over 100 invited lectures at international conferences and over 120 invited research seminars at institutions.
Research Interest
Lipidomics
Biography
Dr. Alejandro Gugliucci is a founding faculty member at Touro University, California, USA which he joined in 1997. He earned his MD and Board Certification in Laboratory Medicine from the University of the Republic, Uruguay. He obtained his PhD in Biochemistry at the University Louis Pasteur of Strasbourg, France. His postdoctoral fellowship in Cell Biology was carried out at the University of Montreal, Canada, where he also worked a few years as a faculty member before moving to the USA. In his alma mater he was a professor in the Biochemistry and Clinical Pathology departments where he was Head of the Lipoprotein Metabolism division at 20-floor, 800 bed hospital for more than 10 years. He was a visiting professor in Tokyo Juntendo University and Niigata Medical School, Japan in 1998 and at the University of Sao Paulo, Brazil in 2007. He has been Full Professor of Biochemistry for the past 8 years. He served as COM Research Director then Associate Dean for Research for the past 10 years leading the exponential growth of research at TUC, the most significant in the Touro College system. He has been recently appointed as University Director of Research Development and Sponsored Programs.
Research Interest
Diabetes mellitus and lipoprotein metabolism.
Biography
Nathan D. Wong, PhD is Professor and Director of the Heart Disease Prevention Program in the Division of Cardiology at University of California, Irvine School of Medicine. He is also Adjunct Professor of Epidemiology at UC Irvine and UCLA. Holding PhD and MPH degrees in epidemiology from Yale University, he is also a Fellow of the American College of Cardiology and the American Heart Association Council on Epidemiology and Prevention. He is Immediate Past President of the American Society for Preventive Cardiology. Dr. Wong has been an investigator or collaborator with numerous large-scale NIH-sponsored studies including the Framingham Heart Study, Women’s Health Initiative, Antihypertensive Lipid-Lowering to Prevent Heart Attack Trial, and the Multiethnic Study of Atherosclerosis. He regularly lectures nationally and internationally on his research in various topics in preventive cardiology and is a member of Who’s Who in America and Who’s Who in the World. With over 20 years of experience as a cardiovascular epidemiologist, Dr. Wong has edited or co-edited four clinical references. He has also authored or co-authored over 200 peer-reviewed manuscripts in his principal research areas of subclinical atherosclerosis, metabolic syndrome, diabetes, and lipids and hypertension, and serves on the editorial boards of several noted journals in the areas of cardiovascular disease and diabetes.
Research Interest
cardiovascular disease and diabetes